ArticleJournal of medical case reports2023

Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report.

Auro Del Giglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.